Artificial intelligence in cardiology refers to computer systems that learn from large datasets of heart-related information, such as ECGs, ultrasound images, and patient records, to detect disease, predict outcomes, and assist cardiologists in making faster, more accurate decisions. These tools are already in clinical use: as of early 2026, the FDA has authorized over 1,450 AI-enabled medical devices across specialties, with cardiovascular applications among the most prominent categories.
AI in this field isn’t one single technology. It spans everything from algorithms that read heart rhythms on your smartwatch to systems that automatically measure heart function from ultrasound scans. Here’s how it’s actually being applied.
How AI Reads Heart Rhythms
One of the most mature uses of AI in cardiology is interpreting electrocardiograms, the electrical tracings of your heartbeat. Detecting atrial fibrillation, the most common dangerous heart rhythm disorder, is where AI has proven especially strong. In a study of over 180,000 ECGs from nearly 71,000 patients, a deep learning model achieved 80% diagnostic accuracy for atrial fibrillation, outperforming cardiologists who scored 75% on the same dataset. The AI model showed a sensitivity of about 87% (meaning it caught most true cases) and a specificity above 99% (meaning it rarely flagged someone who didn’t have the condition).
These algorithms work by training on thousands or millions of labeled ECG recordings. The system learns to recognize the subtle electrical patterns that distinguish a normal rhythm from an abnormal one. In some cases, AI can even detect patterns invisible to the human eye, identifying patients at risk for atrial fibrillation before they’ve ever had a documented episode.
Automated Heart Imaging
Echocardiography, the ultrasound scan of your heart, is one of the most common tests in cardiology. Interpreting it requires measuring things like how much blood the heart pumps with each beat (ejection fraction), chamber volumes, and how the heart muscle contracts. These measurements traditionally take significant time and vary depending on who’s doing the reading.
AI now automates many of these measurements. Several companies have received FDA clearance for tools that calculate ejection fraction and analyze heart muscle strain automatically. When tested against expert human readers, these automated measurements show correlation coefficients above 0.9, which indicates near-identical results. One validation study found that AI-driven measurements had better consistency between different readers than manual methods, particularly for ejection fractions in the 45% to 60% range, a clinically important zone where decisions about treatment often hinge on small differences.
The technology has even been paired with handheld ultrasound devices. In one study, medical students using an AI-powered portable scanner produced ejection fraction estimates that closely matched those of experienced cardiologists doing visual assessments. This could eventually bring reliable cardiac screening to settings that lack specialist coverage. That said, early versions of these tools had issues: one AI model trained on a public dataset incorrectly included internal heart structures in its measurements, leading it to underestimate heart chamber size. These kinds of training data problems are a reminder that the algorithms are only as good as the data they learn from.
Predicting Hospital Readmissions
Heart failure is one of the leading causes of hospital readmission, and AI models are being developed to predict which patients are most likely to bounce back after discharge. In one study, a machine learning model achieved 89.4% accuracy in classifying which heart failure patients would be readmitted versus those who wouldn’t, with about 88% sensitivity and 90% specificity. Interestingly, simpler machine learning approaches outperformed more complex deep learning models for this particular task, likely because the datasets involved are still relatively small compared to image-based applications.
These predictive tools pull from multiple data streams. Some incorporate signals from sensors placed on the chest that track how the heart’s mechanical function changes before and after physical activity. Patients whose readings stayed nearly the same before and after a walking test tended to be in worse shape, a sign their cardiovascular system had little reserve left. The goal is to flag deterioration early enough to intervene before a crisis.
Wearables and Remote Monitoring
Consumer wearables have brought AI-powered cardiac monitoring to millions of people. The Apple Watch, for example, has FDA clearance for an ECG feature that detects atrial fibrillation with up to 98.3% sensitivity and 99.6% specificity. That translates to a false positive rate under 1%, which is remarkably low for a consumer device. Beyond atrial fibrillation, smartwatch ECGs can also flag first-degree heart block, premature ventricular contractions, and abnormally wide electrical signals in the heart’s conduction system.
Smart rings are catching up. A meta-analysis found they can detect atrial fibrillation with 96.9% accuracy, 98.9% sensitivity, and 94.3% specificity. The tradeoff is a higher false positive rate (about 5.7% compared to under 1% for smartwatches), which means more unnecessary worry for healthy wearers. Both categories of devices use a combination of electrical heart signals and pulse-wave monitoring through the skin to continuously track rhythm in the background of daily life.
Genetic Risk and Precision Medicine
AI is also changing how genetic information feeds into heart disease risk assessment. Traditional risk calculators use a handful of factors like age, blood pressure, and cholesterol. Polygenic risk scores take a different approach, combining the effects of hundreds or thousands of small genetic variations, each individually weak, into a single number that estimates your inherited risk for conditions like coronary artery disease, heart failure, or atrial fibrillation.
The challenge is that genetic datasets are enormous and the interactions between genes, lifestyle, and lab results are too complex for conventional statistics to untangle. AI methods can reduce this complexity, identifying the most meaningful patterns across millions of data points. A polygenic risk score built with AI can integrate your genetic profile alongside lifestyle factors, blood biomarkers, and imaging data to produce a more personalized estimate than any single test alone. This is still an evolving field, but it represents a shift toward identifying high-risk individuals years before symptoms appear.
Impact on Clinical Workflow
AI doesn’t just help with diagnosis. It’s also reducing the administrative load that contributes to physician burnout. A study published in JAMA Network Open found that ambient AI tools, which listen to patient-doctor conversations and automatically draft clinical notes, saved physicians about 10.8 minutes per workday. That may sound modest, but across weeks and months it adds up. A separate evaluation of a different tool found after-hours charting dropped by about 5 minutes per day in the first three months, though the benefit faded over six months.
For imaging-heavy specialties like cardiology, automated measurements on echocardiograms can cut reporting time substantially. Instead of manually tracing heart chambers frame by frame, a cardiologist can review AI-generated measurements and make corrections where needed. This shifts the role from data entry toward clinical judgment.
Bias and Accuracy Gaps
One of the most pressing concerns is that AI tools don’t perform equally well for everyone. A systematic review in the European Journal of Radiology found that 82% of existing AI models in cardiovascular medicine showed different accuracy levels across racial and ethnic groups. In practical terms, an algorithm trained primarily on data from one population may miss disease or misclassify risk in another.
This isn’t a theoretical problem. One study used data from the Multi-Ethnic Study of Atherosclerosis, which included participants from multiple racial backgrounds, to build a model detecting thickening of the heart’s main pumping chamber. The researchers found performance varied by group. Only 2 of 11 studies reviewed found no differences in AI model outcomes across ethnicities. The root cause is usually training data that underrepresents certain populations, meaning the algorithm simply hasn’t seen enough examples to learn the full range of normal variation. Fixing this requires deliberately building diverse datasets and testing models across demographic groups before deployment.
How These Systems Actually Learn
Most AI tools in cardiology fall into two broad categories. Machine learning algorithms work with structured data, things like tables of patient characteristics, lab values, and vital signs. They find statistical patterns in labeled datasets where the correct answer is already known (a process called supervised learning) or discover hidden groupings in unlabeled data (unsupervised learning).
Deep learning is a subset of machine learning that uses layered neural networks, loosely inspired by the brain’s architecture. Each layer processes the data at a higher level of abstraction than the one before it. This makes deep learning particularly good at interpreting images (like echocardiograms or cardiac MRIs), analyzing complex waveforms (like ECGs), and recognizing patterns in raw, unstructured data. It’s the reason AI can look at a heart ultrasound and identify the borders of a chamber, or scan a rhythm strip and catch a subtle arrhythmia that a tired clinician might overlook.